Sökning: onr:"swepub:oai:prod.swepub.kib.ki.se:142209073" > The FANCM:p.Arg658*...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 21853naa a2206565 4500 | |
001 | oai:prod.swepub.kib.ki.se:142209073 | |
003 | SwePub | |
008 | 240701s2019 | |||||||||||000 ||eng| | |
009 | oai:DiVA.org:uu-397654 | |
009 | oai:lup.lub.lu.se:c1cc6d81-4544-45eb-b7dc-dd5e1a5e72ba | |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1422090732 URI |
024 | 7 | a https://doi.org/10.1038/s41523-019-0127-52 DOI |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-3976542 URI |
024 | 7 | a https://lup.lub.lu.se/record/c1cc6d81-4544-45eb-b7dc-dd5e1a5e72ba2 URI |
040 | a (SwePub)kid (SwePub)uud (SwePub)lu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Figlioli, Gu IFOM FIRC Inst Mol Oncol, Genome Diagnost Program, Milan, Italy,IFOM - The FIRC Institute of Molecular Oncology4 aut |
245 | 1 0 | a The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer |
264 | c 2019-11-01 | |
264 | 1 | b Springer Science and Business Media LLC,c 2019 |
500 | a For complete list of authors see http://dx.doi.org/10.1038/s41523-019-0127-5 | |
520 | a Breast cancer is a common disease partially caused by genetic risk factors. Germline pathogenic variants in DNA repair genes BRCA1, BRCA2, PALB2, ATM, and CHEK2 are associated with breast cancer risk. FANCM, which encodes for a DNA translocase, has been proposed as a breast cancer predisposition gene, with greater effects for the ER-negative and triple-negative breast cancer (TNBC) subtypes. We tested the three recurrent protein-truncating variants FANCM:p.Arg658*, p.Gln1701*, and p.Arg1931* for association with breast cancer risk in 67,112 cases, 53,766 controls, and 26,662 carriers of pathogenic variants of BRCA1 or BRCA2. These three variants were also studied functionally by measuring survival and chromosome fragility in FANCM−/− patient-derived immortalized fibroblasts treated with diepoxybutane or olaparib. We observed that FANCM:p.Arg658* was associated with increased risk of ER-negative disease and TNBC (OR = 2.44, P = 0.034 and OR = 3.79; P = 0.009, respectively). In a country-restricted analysis, we confirmed the associations detected for FANCM:p.Arg658* and found that also FANCM:p.Arg1931* was associated with ER-negative breast cancer risk (OR = 1.96; P = 0.006). The functional results indicated that all three variants were deleterious affecting cell survival and chromosome stability with FANCM:p.Arg658* causing more severe phenotypes. In conclusion, we confirmed that the two rare FANCM deleterious variants p.Arg658* and p.Arg1931* are risk factors for ER-negative and TNBC subtypes. Overall our data suggest that the effect of truncating variants on breast cancer risk may depend on their position in the gene. Cell sensitivity to olaparib exposure, identifies a possible therapeutic option to treat FANCM-associated tumors. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng |
653 | a arginine | |
653 | a arginine 658 | |
653 | a ATM protein | |
653 | a BRCA1 protein | |
653 | a BRCA2 protein | |
653 | a butadiene diepoxide | |
653 | a checkpoint kinase 2 | |
653 | a olaparib | |
653 | a partner and localizer of BRCA2 | |
653 | a unclassified drug | |
653 | a Article | |
653 | a ATM protein gene | |
653 | a BRCA1 protein gene | |
653 | a BRCA2 protein gene | |
653 | a cell survival | |
653 | a checkpoint kinase 2 gene | |
653 | a chromosomal instability | |
653 | a chromosome fragility | |
653 | a controlled study | |
653 | a FANCM gene | |
653 | a female | |
653 | a gene | |
653 | a gene expression | |
653 | a gene mutation | |
653 | a genotype | |
653 | a human | |
653 | a informed consent | |
653 | a major clinical study | |
653 | a mRNA expression level | |
653 | a partner and localizer of BRCA2 gene | |
653 | a phenotype | |
653 | a priority journal | |
653 | a risk factor | |
653 | a sensitivity analysis | |
653 | a survival rate | |
653 | a triple negative breast cancer | |
653 | a Western blotting | |
700 | 1 | a Bogliolo, M4 aut |
700 | 1 | a Catucci, I4 aut |
700 | 1 | a Caleca, L4 aut |
700 | 1 | a Lasheras, SV4 aut |
700 | 1 | a Pujol, R4 aut |
700 | 1 | a Kiiski, JI4 aut |
700 | 1 | a Muranen, TA4 aut |
700 | 1 | a Barnes, DR4 aut |
700 | 1 | a Dennis, J4 aut |
700 | 1 | a Michailidou, K4 aut |
700 | 1 | a Bolla, MK4 aut |
700 | 1 | a Leslie, G4 aut |
700 | 1 | a Aalfs, CM4 aut |
700 | 1 | a Adank, MA4 aut |
700 | 1 | a Adlard, J4 aut |
700 | 1 | a Agata, S4 aut |
700 | 1 | a Cadoo, K4 aut |
700 | 1 | a Agnarsson, BA4 aut |
700 | 1 | a Ahearn, T4 aut |
700 | 1 | a Aittomaki, K4 aut |
700 | 1 | a Ambrosone, CB4 aut |
700 | 1 | a Andrews, L4 aut |
700 | 1 | a Anton-Culver, H4 aut |
700 | 1 | a Antonenkova, NN4 aut |
700 | 1 | a Arndt, V4 aut |
700 | 1 | a Arnold, N4 aut |
700 | 1 | a Aronson, KJ4 aut |
700 | 1 | a Arun, BK4 aut |
700 | 1 | a Asseryanis, E4 aut |
700 | 1 | a Auber, B4 aut |
700 | 1 | a Auvinen, P4 aut |
700 | 1 | a Azzollini, J4 aut |
700 | 1 | a Balmana, J4 aut |
700 | 1 | a Barkardottir, RB4 aut |
700 | 1 | a Barrowdale, D4 aut |
700 | 1 | a Barwell, J4 aut |
700 | 1 | a Freeman, LEB4 aut |
700 | 1 | a Beauparlant, CJ4 aut |
700 | 1 | a Beckmann, MW4 aut |
700 | 1 | a Behrens, S4 aut |
700 | 1 | a Benitez, J4 aut |
700 | 1 | a Berger, R4 aut |
700 | 1 | a Bermisheva, M4 aut |
700 | 1 | a Blanco, AM4 aut |
700 | 1 | a Blomqvist, C4 aut |
700 | 1 | a Bogdanova, NV4 aut |
700 | 1 | a Bojesen, A4 aut |
700 | 1 | a Bojesen, SE4 aut |
700 | 1 | a Bonanni, B4 aut |
700 | 1 | a Borg, A4 aut |
700 | 1 | a Brady, AF4 aut |
700 | 1 | a Brauch, H4 aut |
700 | 1 | a Brenner, Hermannu German Cancer Research Centre4 aut0 (Swepub:lu)he5674br |
700 | 1 | a Bruning, T4 aut |
700 | 1 | a Burwinkel, B4 aut |
700 | 1 | a Buys, SS4 aut |
700 | 1 | a Caldes, T4 aut |
700 | 1 | a Caliebe, A4 aut |
700 | 1 | a Caligo, MA4 aut |
700 | 1 | a Campa, D4 aut |
700 | 1 | a Campbell, IG4 aut |
700 | 1 | a Canzian, F4 aut |
700 | 1 | a Castelao, JE4 aut |
700 | 1 | a Chang-Claude, J4 aut |
700 | 1 | a Chanock, SJ4 aut |
700 | 1 | a Claes, KBM4 aut |
700 | 1 | a Clarke, CL4 aut |
700 | 1 | a Collavoli, A4 aut |
700 | 1 | a Conner, TA4 aut |
700 | 1 | a Cox, DG4 aut |
700 | 1 | a Cybulski, C4 aut |
700 | 1 | a Czene, Ku Karolinska Institutet4 aut |
700 | 1 | a Daly, MB4 aut |
700 | 1 | a de la Hoya, M4 aut |
700 | 1 | a Devilee, P4 aut |
700 | 1 | a Diez, O4 aut |
700 | 1 | a Ding, YC4 aut |
700 | 1 | a Dite, GS4 aut |
700 | 1 | a Ditsch, N4 aut |
700 | 1 | a Domchek, SM4 aut |
700 | 1 | a Dorfling, CM4 aut |
700 | 1 | a dos-Santos-Silva, I4 aut |
700 | 1 | a Durda, K4 aut |
700 | 1 | a Dwek, M4 aut |
700 | 1 | a Eccles, DM4 aut |
700 | 1 | a Ekici, AB4 aut |
700 | 1 | a Eliassen, AH4 aut |
700 | 1 | a Ellberg, Carolinau Lund University,Lunds universitet,Tumörmikromiljö,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Tumor microenvironment,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine4 aut0 (Swepub:lu)med-elc |
700 | 1 | a Eriksson, Mu Karolinska Institutet4 aut |
700 | 1 | a Evans, DG4 aut |
700 | 1 | a Fasching, PAu IFOM - The FIRC Institute of Molecular Oncology4 aut |
700 | 1 | a Figueroa, J4 aut |
700 | 1 | a Flyger, H4 aut |
700 | 1 | a Foulkes, WD4 aut |
700 | 1 | a Friebel, TM4 aut |
700 | 1 | a Friedman, E4 aut |
700 | 1 | a Gabrielson, Mu Karolinska Institutet4 aut |
700 | 1 | a Gaddam, P4 aut |
700 | 1 | a Gago-Dominguez, M4 aut |
700 | 1 | a Gao, C4 aut |
700 | 1 | a Gapstur, SM4 aut |
700 | 1 | a Garber, J4 aut |
700 | 1 | a Garcia-Closas, M4 aut |
700 | 1 | a Garcia-Saenz, JA4 aut |
700 | 1 | a Gaudet, MM4 aut |
700 | 1 | a Gayther, SA4 aut |
700 | 1 | a Giles, GG4 aut |
700 | 1 | a Glendon, G4 aut |
700 | 1 | a Godwin, AK4 aut |
700 | 1 | a Goldberg, MS4 aut |
700 | 1 | a Goldgar, DE4 aut |
700 | 1 | a Guenel, P4 aut |
700 | 1 | a Gutierrez-Barrera, AM4 aut |
700 | 1 | a Haeberle, L4 aut |
700 | 1 | a Haiman, CA4 aut |
700 | 1 | a Hakansson, Nu Karolinska Institutet4 aut |
700 | 1 | a Hall, Peru Lund University,Lunds universitet,Karolinska Institutet,Tumörmikromiljö,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Tumor microenvironment,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine4 aut0 (Swepub:lu)pe3137ha |
700 | 1 | a Hamann, U4 aut |
700 | 1 | a Harrington, PA4 aut |
700 | 1 | a Hein, A4 aut |
700 | 1 | a Heyworth, J4 aut |
700 | 1 | a Hillemanns, P4 aut |
700 | 1 | a Hollestelle, A4 aut |
700 | 1 | a Hopper, JL4 aut |
700 | 1 | a Hosgood, HD4 aut |
700 | 1 | a Howell, A4 aut |
700 | 1 | a Hu, CL4 aut |
700 | 1 | a Hulick, PJ4 aut |
700 | 1 | a Hunter, DJ4 aut |
700 | 1 | a Imyanitov, EN4 aut |
700 | 1 | a Isaacs, C4 aut |
700 | 1 | a Jakimovska, M4 aut |
700 | 1 | a Jakubowska, A4 aut |
700 | 1 | a James, P4 aut |
700 | 1 | a Janavicius, R4 aut |
700 | 1 | a Janni, W4 aut |
700 | 1 | a John, EM4 aut |
700 | 1 | a Jones, ME4 aut |
700 | 1 | a Jung, A4 aut |
700 | 1 | a Kaaks, R4 aut |
700 | 1 | a Karlan, BY4 aut |
700 | 1 | a Khusnutdinova, E4 aut |
700 | 1 | a Kitahara, CM4 aut |
700 | 1 | a Konstantopoulou, I4 aut |
700 | 1 | a Koutros, S4 aut |
700 | 1 | a Kraft, P4 aut |
700 | 1 | a Lambrechts, D4 aut |
700 | 1 | a Lazaro, C4 aut |
700 | 1 | a Le Marchand, L4 aut |
700 | 1 | a Lester, J4 aut |
700 | 1 | a Lesueur, F4 aut |
700 | 1 | a Lilyquist, J4 aut |
700 | 1 | a Loud, JT4 aut |
700 | 1 | a Lu, KRH4 aut |
700 | 1 | a Luben, RN4 aut |
700 | 1 | a Lubinski, J4 aut |
700 | 1 | a Mannermaa, A4 aut |
700 | 1 | a Manoochehri, M4 aut |
700 | 1 | a Manoukian, S4 aut |
700 | 1 | a Margolin, Su Karolinska Institutet4 aut |
700 | 1 | a Martens, JWM4 aut |
700 | 1 | a Maurer, T4 aut |
700 | 1 | a Mavroudis, D4 aut |
700 | 1 | a Mebirouk, N4 aut |
700 | 1 | a Meindl, A4 aut |
700 | 1 | a Menon, U4 aut |
700 | 1 | a Miller, A4 aut |
700 | 1 | a Montagna, M4 aut |
700 | 1 | a Nathanson, KL4 aut |
700 | 1 | a Neuhausen, SL4 aut |
700 | 1 | a Newman, WG4 aut |
700 | 1 | a Nguyen-Dumont, T4 aut |
700 | 1 | a Nielsen, FC4 aut |
700 | 1 | a Nielsen, S4 aut |
700 | 1 | a Nikitina-Zake, L4 aut |
700 | 1 | a Offit, K4 aut |
700 | 1 | a Olah, E4 aut |
700 | 1 | a Olopade, OI4 aut |
700 | 1 | a Olshan, AF4 aut |
700 | 1 | a Olson, JE4 aut |
700 | 1 | a Olsson, Håkanu Lund University,Lunds universitet,Medicinsk onkologi,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Medical oncology,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine4 aut0 (Swepub:lu)onk-hol |
700 | 1 | a Osorio, A4 aut |
700 | 1 | a Ottini, L4 aut |
700 | 1 | a Peissel, B4 aut |
700 | 1 | a Peixoto, A4 aut |
700 | 1 | a Peto, J4 aut |
700 | 1 | a Plaseska-Karanfilska, D4 aut |
700 | 1 | a Pocza, T4 aut |
700 | 1 | a Presneau, N4 aut |
700 | 1 | a Pujana, MA4 aut |
700 | 1 | a Punie, K4 aut |
700 | 1 | a Rack, B4 aut |
700 | 1 | a Rantala, Ju Karolinska Institutet4 aut |
700 | 1 | a Rashid, MU4 aut |
700 | 1 | a Rau-Murthy, R4 aut |
700 | 1 | a Rennert, G4 aut |
700 | 1 | a Lejbkowicz, F4 aut |
700 | 1 | a Rhenius, V4 aut |
700 | 1 | a Romero, A4 aut |
700 | 1 | a Rookus, MA4 aut |
700 | 1 | a Ross, EA4 aut |
700 | 1 | a Rossing, M4 aut |
700 | 1 | a Rudaitis, V4 aut |
700 | 1 | a Ruebner, M4 aut |
700 | 1 | a Saloustros, E4 aut |
700 | 1 | a Sanden, K4 aut |
700 | 1 | a Santamarina, M4 aut |
700 | 1 | a Scheuner, MT4 aut |
700 | 1 | a Schmutzler, RK4 aut |
700 | 1 | a Schneider, M4 aut |
700 | 1 | a Scott, C4 aut |
700 | 1 | a Senter, L4 aut |
700 | 1 | a Shah, M4 aut |
700 | 1 | a Sharma, P4 aut |
700 | 1 | a Shu, XO4 aut |
700 | 1 | a Simard, J4 aut |
700 | 1 | a Singer, CF4 aut |
700 | 1 | a Sohn, C4 aut |
700 | 1 | a Soucy, P4 aut |
700 | 1 | a Southey, MC4 aut |
700 | 1 | a Spinelli, JJ4 aut |
700 | 1 | a Steele, L4 aut |
700 | 1 | a Stoppa-Lyonnet, D4 aut |
700 | 1 | a Tapper, WJ4 aut |
700 | 1 | a Teixeira, MR4 aut |
700 | 1 | a Terry, MB4 aut |
700 | 1 | a Thomassen, M4 aut |
700 | 1 | a Thompson, J4 aut |
700 | 1 | a Thull, DL4 aut |
700 | 1 | a Tischkowitz, M4 aut |
700 | 1 | a Tollenaar, RAEM4 aut |
700 | 1 | a Torres, D4 aut |
700 | 1 | a Troester, MA4 aut |
700 | 1 | a Truong, T4 aut |
700 | 1 | a Tung, N4 aut |
700 | 1 | a Untch, M4 aut |
700 | 1 | a Vachon, CM4 aut |
700 | 1 | a van Rensburg, EJ4 aut |
700 | 1 | a van Veen, EM4 aut |
700 | 1 | a Vega, A4 aut |
700 | 1 | a Viel, A4 aut |
700 | 1 | a Wappenschmidt, B4 aut |
700 | 1 | a Weitzel, JN4 aut |
700 | 1 | a Wendt, C4 aut |
700 | 1 | a Wieme, G4 aut |
700 | 1 | a Wolk, Alicjau Uppsala universitet,Karolinska Institutet,Ortopedi,Karolinska Inst, Inst Environm Med, Stockholm, Sweden4 aut0 (Swepub:uu)alwol516 |
700 | 1 | a Yang, XHR4 aut |
700 | 1 | a Zheng, W4 aut |
700 | 1 | a Ziogas, A4 aut |
700 | 1 | a Zorn, KK4 aut |
700 | 1 | a Dunning, AM4 aut |
700 | 1 | a Lush, M4 aut |
700 | 1 | a Wang, Q4 aut |
700 | 1 | a McGuffog, L4 aut |
700 | 1 | a Parsons, MT4 aut |
700 | 1 | a Pharoah, PDP4 aut |
700 | 1 | a Fostira, F4 aut |
700 | 1 | a Toland, AE4 aut |
700 | 1 | a Andrulis, IL4 aut |
700 | 1 | a Ramus, SJ4 aut |
700 | 1 | a Swerdlow, AJ4 aut |
700 | 1 | a Greene, MH4 aut |
700 | 1 | a Chung, WK4 aut |
700 | 1 | a Milne, RL4 aut |
700 | 1 | a Chenevix-Trench, G4 aut |
700 | 1 | a Dork, T4 aut |
700 | 1 | a Schmidt, MK4 aut |
700 | 1 | a Easton, DF4 aut |
700 | 1 | a Radice, P4 aut |
700 | 1 | a Hahnen, E4 aut |
700 | 1 | a Antoniou, AC4 aut |
700 | 1 | a Couch, FJ4 aut |
700 | 1 | a Nevanlinna, H4 aut |
700 | 1 | a Surralles, J4 aut |
700 | 1 | a Peterlongo, P4 aut |
700 | 1 | a Balleine, R4 aut |
700 | 1 | a Baxter, R4 aut |
700 | 1 | a Braye, S4 aut |
700 | 1 | a Carpenter, J4 aut |
700 | 1 | a Dahlstrom, J4 aut |
700 | 1 | a Forbes, J4 aut |
700 | 1 | a Lee, CS4 aut |
700 | 1 | a Marsh, D4 aut |
700 | 1 | a Morey, A4 aut |
700 | 1 | a Pathmanathan, N4 aut |
700 | 1 | a Scott, R4 aut |
700 | 1 | a Simpson, P4 aut |
700 | 1 | a Spigelman, A4 aut |
700 | 1 | a Wilcken, N4 aut |
700 | 1 | a Yip, D4 aut |
700 | 1 | a Zeps, N4 aut |
700 | 1 | a Belotti, M4 aut |
700 | 1 | a Bertrand, O4 aut |
700 | 1 | a Birot, AM4 aut |
700 | 1 | a Buecher, B4 aut |
700 | 1 | a Caputo, S4 aut |
700 | 1 | a Dupre, A4 aut |
700 | 1 | a Fourme, E4 aut |
700 | 1 | a Gauthier-Villars, M4 aut |
700 | 1 | a Golmard, L4 aut |
700 | 1 | a Le Mentec, M4 aut |
700 | 1 | a Moncoutier, V4 aut |
700 | 1 | a de Pauw, A4 aut |
700 | 1 | a Saule, C4 aut |
700 | 1 | a Boutry-Kryza, N4 aut |
700 | 1 | a Calender, A4 aut |
700 | 1 | a Giraud, S4 aut |
700 | 1 | a Leone, M4 aut |
700 | 1 | a Bressac-de-Paillerets, B4 aut |
700 | 1 | a Caron, O4 aut |
700 | 1 | a Guillaud-Bataille, M4 aut |
700 | 1 | a Bignon, YJ4 aut |
700 | 1 | a Uhrhammer, N4 aut |
700 | 1 | a Bonadona, V4 aut |
700 | 1 | a Lasset, C4 aut |
700 | 1 | a Berthet, P4 aut |
700 | 1 | a Castera, L4 aut |
700 | 1 | a Vaur, D4 aut |
700 | 1 | a Bourdon, V4 aut |
700 | 1 | a Nogues, C4 aut |
700 | 1 | a Noguchi, T4 aut |
700 | 1 | a Popovici, C4 aut |
700 | 1 | a Remenieras, A4 aut |
700 | 1 | a Sobol, H4 aut |
700 | 1 | a Coupier, I4 aut |
700 | 1 | a Pujol, P4 aut |
700 | 1 | a Adenis, C4 aut |
700 | 1 | a Dumont, A4 aut |
700 | 1 | a Revillion, F4 aut |
700 | 1 | a Muller, D4 aut |
700 | 1 | a Barouk-Simonet, E4 aut |
700 | 1 | a Bonnet, F4 aut |
700 | 1 | a Bubien, V4 aut |
700 | 1 | a Longy, M4 aut |
700 | 1 | a Sevenet, N4 aut |
700 | 1 | a Gladieff, L4 aut |
700 | 1 | a Guimbaud, R4 aut |
700 | 1 | a Feillel, V4 aut |
700 | 1 | a Toulas, C4 aut |
700 | 1 | a Dreyfus, H4 aut |
700 | 1 | a Leroux, CD4 aut |
700 | 1 | a Peysselon, M4 aut |
700 | 1 | a Rebischung, C4 aut |
700 | 1 | a Legrand, C4 aut |
700 | 1 | a Baurand, A4 aut |
700 | 1 | a Bertolone, G4 aut |
700 | 1 | a Coron, F4 aut |
700 | 1 | a Faivre, L4 aut |
700 | 1 | a Jacquot, C4 aut |
700 | 1 | a Lizard, S4 aut |
700 | 1 | a Kientz, C4 aut |
700 | 1 | a Lebrun, M4 aut |
700 | 1 | a Prieur, F4 aut |
700 | 1 | a Fert-Ferrer, S4 aut |
700 | 1 | a Mari, V4 aut |
700 | 1 | a Venat-Bouvet, L4 aut |
700 | 1 | a Bezieau, S4 aut |
700 | 1 | a Delnatte, C4 aut |
700 | 1 | a Mortemousque, I4 aut |
700 | 1 | a Colas, C4 aut |
700 | 1 | a Coulet, F4 aut |
700 | 1 | a Soubrier, F4 aut |
700 | 1 | a Warcoin, M4 aut |
700 | 1 | a Bronner, M4 aut |
700 | 1 | a Sokolowska, J4 aut |
700 | 1 | a Collonge-Rame, MA4 aut |
700 | 1 | a Damette, A4 aut |
700 | 1 | a Gesta, P4 aut |
700 | 1 | a Lallaoui, H4 aut |
700 | 1 | a Chiesa, J4 aut |
700 | 1 | a Molina-Gomes, D4 aut |
700 | 1 | a Ingster, O4 aut |
700 | 1 | a Manouvrier-Hanu, S4 aut |
700 | 1 | a Lejeune, S4 aut |
700 | 1 | a Aghmesheh, M4 aut |
700 | 1 | a Greening, S4 aut |
700 | 1 | a Amor, D4 aut |
700 | 1 | a Gattas, M4 aut |
700 | 1 | a Botes, L4 aut |
700 | 1 | a Buckley, M4 aut |
700 | 1 | a Friedlander, M4 aut |
700 | 1 | a Koehler, J4 aut |
700 | 1 | a Meiser, B4 aut |
700 | 1 | a Saleh, M4 aut |
700 | 1 | a Salisbury, E4 aut |
700 | 1 | a Trainer, A4 aut |
700 | 1 | a Tucker, K4 aut |
700 | 1 | a Antill, Y4 aut |
700 | 1 | a Dobrovic, A4 aut |
700 | 1 | a Fellows, A4 aut |
700 | 1 | a Fox, S4 aut |
700 | 1 | a Harris, M4 aut |
700 | 1 | a Nightingale, S4 aut |
700 | 1 | a Phillips, K4 aut |
700 | 1 | a Sambrook, J4 aut |
700 | 1 | a Thorne, H4 aut |
700 | 1 | a Armitage, S4 aut |
700 | 1 | a Arnold, L4 aut |
700 | 1 | a Kefford, R4 aut |
700 | 1 | a Kirk, J4 aut |
700 | 1 | a Rickard, E4 aut |
700 | 1 | a Bastick, P4 aut |
700 | 1 | a Beesley, J4 aut |
700 | 1 | a Hayward, N4 aut |
700 | 1 | a Spurdle, A4 aut |
700 | 1 | a Walker, L4 aut |
700 | 1 | a Beilby, J4 aut |
700 | 1 | a Saunders, C4 aut |
700 | 1 | a Bennett, I4 aut |
700 | 1 | a Blackburn, A4 aut |
700 | 1 | a Bogwitz, M4 aut |
700 | 1 | a Gaff, C4 aut |
700 | 1 | a Lindeman, G4 aut |
700 | 1 | a Pachter, N4 aut |
700 | 1 | a Scott, C4 aut |
700 | 1 | a Sexton, A4 aut |
700 | 1 | a Visvader, J4 aut |
700 | 1 | a Taylor, J4 aut |
700 | 1 | a Winship, I4 aut |
700 | 1 | a Brennan, M4 aut |
700 | 1 | a Brown, M4 aut |
700 | 1 | a French, J4 aut |
700 | 1 | a Edwards, S4 aut |
700 | 1 | a Burgess, M4 aut |
700 | 1 | a Burke, J4 aut |
700 | 1 | a Patterson, B4 aut |
700 | 1 | a Butow, P4 aut |
700 | 1 | a Culling, B4 aut |
700 | 1 | a Caldon, L4 aut |
700 | 1 | a Callen, D4 aut |
700 | 1 | a Chauhan, D4 aut |
700 | 1 | a Eisenbruch, M4 aut |
700 | 1 | a Heiniger, L4 aut |
700 | 1 | a Chauhan, M4 aut |
700 | 1 | a Christian, A4 aut |
700 | 1 | a Dixon, J4 aut |
700 | 1 | a Kidd, A4 aut |
700 | 1 | a Cohen, P4 aut |
700 | 1 | a Colley, A4 aut |
700 | 1 | a Fenton, G4 aut |
700 | 1 | a Crook, A4 aut |
700 | 1 | a Dickson, R4 aut |
700 | 1 | a Field, M4 aut |
700 | 1 | a Cui, J4 aut |
700 | 1 | a Cummings, M4 aut |
700 | 1 | a Dawson, SJ4 aut |
700 | 1 | a DeFazio, A4 aut |
700 | 1 | a Delatycki, M4 aut |
700 | 1 | a Dudding, T4 aut |
700 | 1 | a Edkins, T4 aut |
700 | 1 | a Farshid, G4 aut |
700 | 1 | a Flanagan, J4 aut |
700 | 1 | a Fong, P4 aut |
700 | 1 | a Forrest, L4 aut |
700 | 1 | a Gallego-Ortega, D4 aut |
700 | 1 | a George, P4 aut |
700 | 1 | a Gill, G4 aut |
700 | 1 | a Kollias, J4 aut |
700 | 1 | a Haan, E4 aut |
700 | 1 | a Hart, S4 aut |
700 | 1 | a Jenkins, M4 aut |
700 | 1 | a Hunt, C4 aut |
700 | 1 | a Lakhani, S4 aut |
700 | 1 | a Lipton, L4 aut |
700 | 1 | a Lobb, L4 aut |
700 | 1 | a Mann, G4 aut |
700 | 1 | a McLachlan, SA4 aut |
700 | 1 | a O'Connell, S4 aut |
700 | 1 | a O'Sullivan, S4 aut |
700 | 1 | a Pieper, E4 aut |
700 | 1 | a Robinson, B4 aut |
700 | 1 | a Saunus, J4 aut |
700 | 1 | a Scott, E4 aut |
700 | 1 | a Shelling, A4 aut |
700 | 1 | a Williams, R4 aut |
700 | 1 | a Young, MAu Genome One, Darlinghurst, NSW, Australia4 aut |
710 | 2 | a IFOM FIRC Inst Mol Oncol, Genome Diagnost Program, Milan, Italyb IFOM - The FIRC Institute of Molecular Oncology4 org |
773 | 0 | t NPJ breast cancerd : Springer Science and Business Media LLCg 5, s. 38-q 5<38-x 2374-4677 |
856 | 4 | u https://www.nature.com/articles/s41523-019-0127-5.pdf |
856 | 4 | u https://doi.org/10.1038/s41523-019-0127-5y Fulltext |
856 | 4 | u https://uu.diva-portal.org/smash/get/diva2:1374882/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
856 | 4 | u http://dx.doi.org/10.1038/s41523-019-0127-5x freey FULLTEXT |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:142209073 |
856 | 4 8 | u https://doi.org/10.1038/s41523-019-0127-5 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-397654 |
856 | 4 8 | u https://lup.lub.lu.se/record/c1cc6d81-4544-45eb-b7dc-dd5e1a5e72ba |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy